In general, CML involves a typical driver gene alteration, the BCR::ABL1 fusion gene, and more rare diseases, namely CNL, CEL, and unclassifiable MPN, not otherwise specified, have been treated as independent diseases. The gene discussed is ABL1; the disease is myeloproliferative disorder.